| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.4 |
4e-32 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-12 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-09 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-07 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
| mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-05 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |